Tag: audit trail

Data Integrity Governance in Mergers, Acquisitions and Site Transfers Step-by-Step Guide to Data Integrity Governance in Mergers, Acquisitions and Site Transfers In pharmaceutical manufacturing and clinical operations, maintaining data integrity during organizational changes such as mergers, acquisitions, and site transfers is critical to ensuring compliance with regulatory frameworks including 21 CFR Part 11 and Annex…

Read More “Data Integrity Governance in Mergers, Acquisitions and Site Transfers” »

Using External DI Audits to Validate Internal Controls and Culture Leveraging External Data Integrity Audits to Strengthen Internal Controls and Organizational Culture Data integrity continues to be a cornerstone of pharmaceutical quality systems worldwide, underpinning reliable manufacturing, clinical trials, and regulatory compliance. Global regulators including the FDA, EMA, and MHRA have intensified scrutiny on data…

Read More “Using External DI Audits to Validate Internal Controls and Culture” »

Communicating DI Expectations to External Partners, CMOs and CROs Effective Communication of Data Integrity Expectations to External Partners, CMOs, and CROs Maintaining data integrity within pharmaceutical development and manufacturing is non-negotiable throughout the product lifecycle. The US FDA, EMA, MHRA, and other regulatory agencies hold pharmaceutical companies accountable for ensuring that all GxP records generated…

Read More “Communicating DI Expectations to External Partners, CMOs and CROs” »

Data Integrity in Document Scanning, OCR and Digital Archive Projects Ensuring Data Integrity in Document Scanning, OCR, and Digital Archive Projects: A Step-by-Step Guide Maintaining data integrity throughout pharmaceutical document management processes is essential for compliance with regulatory authorities such as the FDA, EMA, MHRA, and global GMP standards. In regulated pharma environments, scanning of…

Read More “Data Integrity in Document Scanning, OCR and Digital Archive Projects” »

Reducing DI Risk When Sourcing Low-Cost Instruments or Software Solutions Reducing Data Integrity Risk When Sourcing Low-Cost Instruments or Software Solutions: A Step-by-Step GMP Guide Ensuring robust data integrity throughout pharmaceutical manufacturing and quality systems is paramount for compliance with regulatory requirements and maintaining product safety. The challenge grows steeper when organizations opt to source…

Read More “Reducing DI Risk When Sourcing Low-Cost Instruments or Software Solutions” »

Verifying the Integrity of Environmental, Utility and Process Monitoring Data Ensuring Robust Verification of Environmental, Utility and Process Monitoring Data in Pharma Pharmaceutical manufacturers in the US, UK, and EU regions face stringent regulatory expectations to ensure the data integrity of environmental, utility, and process monitoring systems. These systems generate critical GxP records that directly…

Read More “Verifying the Integrity of Environmental, Utility and Process Monitoring Data” »

Managing Data Integrity in Shared Drives, File Servers and Collaboration Tools Step-by-Step Guide to Managing Data Integrity in Shared Drives, File Servers, and Collaboration Tools Ensuring data integrity across shared drives, file servers, and collaborative platforms is a critical challenge for pharmaceutical manufacturers and associated professionals in the US, UK, and EU. Compliance with regulatory…

Read More “Managing Data Integrity in Shared Drives, File Servers and Collaboration Tools” »

Aligning DI Policies With Corporate Information Security and Cyber Controls Step-by-Step Guide to Aligning Data Integrity Policies with Corporate Information Security and Cyber Controls Pharmaceutical organizations operating in the US, UK, and EU markets face complex regulatory requirements governing the integrity, security, and traceability of their electronic GxP records. Data Integrity (DI) is central to…

Read More “Aligning DI Policies With Corporate Information Security and Cyber Controls” »

Incorporating Data Integrity Checks Into PQR/APR and Management Reviews Incorporating Data Integrity Controls into PQR, APR, and Management Review Processes Ensuring data integrity throughout pharmaceutical operations is a regulatory cornerstone underpinning product quality and patient safety. The increasing complexity of electronic data systems and regulatory expectations worldwide—encompassing the US, UK, and EU jurisdictions—requires robust integration…

Read More “Incorporating Data Integrity Checks Into PQR/APR and Management Reviews” »

Handling Anonymous DI Complaints and Whistleblower Allegations Responsibly Step-by-Step Guide to Handling Anonymous Data Integrity Complaints and Whistleblower Allegations in Pharma Data integrity remains a foundational pillar in pharmaceutical manufacturing and quality assurance, as regulatory agencies and global health authorities emphasize its criticality for patient safety and product quality. Recent years have underscored the challenges…

Read More “Handling Anonymous DI Complaints and Whistleblower Allegations Responsibly” »